Navigation Links
Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
Date:7/25/2012

eered to enhance this cancer-selectivity by inactivating its thymidine kinase (TK) gene, thus making it dependent on the cellular TK expressed at persistently high levels in cancer cells. To enhance product efficacy, JX-594 is also engineered to express the immunogenic GM-CSF protein. GM-CSF complements the cancer cell lysis of the product candidate, leading to a cascade of events resulting in tumor necrosis, tumor vasculature shutdown and sustained anti-tumoral immune attack.

Hepatocellular Carcinoma: A Global Unmet Need

Hepatocellular carcinoma is the fifth most common cancer worldwide and the third leading cause of cancer death, with over 600,000 new cases diagnosed annually resulting in more than 90 percent mortality.  The annual incidence rate in the U.S., Europe, Japan and China are estimated to be 20,000, 55,000, 40,000 and 350,000 patients, respectively.

About Jennerex's Partners for JX-594

Transgene (NYSE Euronext Paris: FR0005175080), a bio-pharmaceutical company specialized in the development of immunotherapeutic products, holds an exclusive license to develop and commercialize JX-594 in Europe and neighboring countries. Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, holds an exclusive license to develop and commercialize JX-594 in South Korea, and Lee's Pharmaceutical Ltd. holds an exclusive license to develop and commercialize JX-594 in China.

Transgene, a member of the Institut Merieux Group, is a publicly traded French biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases, and has five compounds in clinical development: TG4010 and JX-594 (TG6006) having completed initial phase II trials, TG4001 in phase IIb trial, TG4040 in phase II trial and TG4023 in phase I trial. Transgene has concluded strategic agreements for the
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
2. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
3. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
4. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
5. Misonix Announces New Distribution Agreement For Panama
6. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
9. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
10. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
11. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Some 2,500 scientists and ... in Montreal for the largest ... a discipline that draws researchers from fields as far ... as diverse as designing new manufacturing processes to creating ... special time because the United Nations has declared 2014 ...
(Date:7/28/2014)...  VigeneTech, Inc, in collaboration with BioLegend, Inc., ... Software, an OEM software solution for analysis of ... offers varieties of bead-based multi-analyte immunoassay products for ... VigeneTech,s data analysis software, FCS data files can ... LEGENDplex™ software is a robust ...
(Date:7/28/2014)... New Zealand , July 28, 2014 /PRNewswire/ ... in Sweden has validated ... multiple vendor platforms and has associated volumetrically assessed ... in Cancer Epidemiology, Biomarkers & Prevention ... mammographic density: a tool for widespread breast cancer ...
Breaking Medicine Technology:All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 2All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 3All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 4All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 5All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 6VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4
... MADRID, Sept. 9 Noscira, a Grupo Zeltia (ZEL.MC) ... treat neurodegenerative diseases, has announced that the U.S. Food ... to its neuroprotector drug Tideglusib (ZentylorTM) to treat Progressive ... A Phase II trial with Tideglusib (ZentylorTM) in PSP ...
... HealthSouth Corporation (NYSE: HLS ) announced today ... dividend of $16.25 per share on its 6.5% Series A ... holders of record on Oct. 1, 2010. ... rehabilitative healthcare services. Operating in 26 states across the country ...
Cached Medicine Technology:FDA Grants Fast Track Status to Tideglusib (ZentylorTM) for Progressive Supranuclear Palsy 2FDA Grants Fast Track Status to Tideglusib (ZentylorTM) for Progressive Supranuclear Palsy 3
(Date:7/28/2014)... 28, 2014 Dawn Echols’ professional ... finance, and music. This experience has honed her ... of psychology. Her professional counseling ( http://dawningphoenix.com ) ... treatment for offenders in domestic violence. , ... LLC, she enjoys counseling individuals and groups for ...
(Date:7/28/2014)... version of a surgical procedure to treat severe chronic ... 90 percent of the time in patients treated at ... Division of Plastic and Reconstructive Surgery report that more ... procedure all of whom had headaches associated with ... a year later. The team,s paper has received ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Shofner ... Operation Military June . Renowned LASIK and Cataract ... to provide significant funds and public awareness for ... retired military personnel and their families. “This was ... proudly give nearly $5,000 to a variety of ...
(Date:7/28/2014)... July 28, 2014 Ticket Down ... tickets in Miami, FL at the Sun Life Stadium ... American football between Argentina and Brazil has is one that ... worldwide, more rivalries are forming on a consistent basis. ... a new height in the recent 2014 World Cup. ...
(Date:7/28/2014)... MONDAY, July 28, 2014 (HealthDay News) -- British researchers ... spread far fewer germs around. In their experiments, ... times more germs from one person to the other ... suggest the more casual exchange might suffice as a ... The findings are published in the August issue of ...
Breaking Medicine News(10 mins):Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3
... member Adrianne Johnson needed to find a primary care physician ... to myRegence.com to compare those recommendations with feedback from other ... the Member Reviews she read on myRegence.com, Johnson was able ... but specialists, as well. , "The reviews on myRegence.com ...
... for improvement in reform proposals for small businesses , ... Business and Entrepreneurship Chair Mary Landrieu, D-La., and Ranking Member ... understand the needs of small businesses in health care reform ... , "We are here today to discuss one of the ...
... Scientists from 16 countries selected for their unconventional projects ... 20 The Bill & Melinda Gates Foundation today ... ideas for transforming health in developing countries. The ... diverse as developing an electronic nose to diagnose tuberculosis ...
... House Majority Leader Steny Hoyer, and Congressman Mark Schauer of ... afternoon in the Capitol with representatives from Easter Seals to ... pre-existing conditions. Shannon Saunders Eaton of Ohio ... told their personal stories as a testament to why we ...
... , An increasing number ... sustainability practices thanks to simplified life-cycle management ... 20 /PRNewswire/ - Carbonostics responds to the growing need ... user-friendly and cost-effective application complete with a comprehensive carbon ...
... Drug given within 4.5 hours still benefits patients, study ... plasminogen activator (tPA) treatment benefits stroke patients when used ... German researchers who said their findings provide further evidence ... three hours to 4.5 hours. , Previously published findings ...
Cached Medicine News:Health News:Regence Takes Community Approach to Provider 'Reviews' 2Health News:Regence Takes Community Approach to Provider 'Reviews' 3Health News:Landrieu, Snowe Champion Small Business Health Care Reform Efforts 2Health News:Bill & Melinda Gates Foundation Funds 76 New Ideas to Improve Global Health, From Chewing Gum to Chocolate 2Health News:Bill & Melinda Gates Foundation Funds 76 New Ideas to Improve Global Health, From Chewing Gum to Chocolate 3Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 2Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 3Health News:Food Industry: Carbonostics Responds To Sustainability Obstacles 2Health News:Food Industry: Carbonostics Responds To Sustainability Obstacles 3Health News:Food Industry: Carbonostics Responds To Sustainability Obstacles 4Health News:Stroke Treatment Window May Allow a Bit More Time 2
...
...
...
Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...
Medicine Products: